Вештачка интелигенција

AI Revolutionizes Drug Discovery and Creation: The Future of Medicine

Summary

Artificial Intelligence (AI) has emerged as a game-changer in the field of medicine, transforming the way drugs are discovered and created. Professor Andrew Hopkins, a former student turned entrepreneur, founded his company, Exscientia, 16 years ago with the aim of […]

AI Revolutionizes Drug Discovery and Creation: The Future of Medicine

Artificial Intelligence (AI) has emerged as a game-changer in the field of medicine, transforming the way drugs are discovered and created. Professor Andrew Hopkins, a former student turned entrepreneur, founded his company, Exscientia, 16 years ago with the aim of using AI to revolutionize the development of life-saving medications. Today, Exscientia is working on projects such as developing a pill for Covid prevention and precise treatments for cancer.

During his doctoral studies at the University of Oxford, Hopkins made a groundbreaking connection between computers and accelerating drug discovery. Instead of relying solely on traditional methods, he pondered how computers could be used to invent drugs more efficiently. This idea became his passion and influenced his career for the next two decades.

Growing up in the shadow of Port Talbot’s steelworks, Professor Hopkins developed a love for scientific disciplines. His parents, Brian and Barbara Hopkins, met while working in one of the local factories in Neath in 1965. From the age of 16, he worked as a scientist in the steelworks during the summer months. Thanks to a sponsored scholarship, he had the opportunity to study chemistry at the University of Manchester. After completing his studies, he was offered a job and returned to the steelworks. This early experience played a crucial role in shaping his scientific education and business acumen.

While AI technology remains controversial, with calls for greater regulation, Hopkins firmly believes that it has the potential to revolutionize healthcare. The cost of drug development is exorbitant, with only around 4% of drugs entering clinical trials proving successful. It takes approximately 15 years to go from an idea to a licensed drug available to patients. By incorporating AI, the process of drug development, testing, and optimization can be streamlined, reducing the number of experiments needed by up to 90% compared to conventional approaches.

Exscientia recently employed AI in a clinical trial by applying precision medicine to a sample of patients with blood cancer. “We tested nearly 140 different drugs, far more than would be possible with a single patient,” explained Professor Hopkins. “This allowed us to gain a deeper understanding of how each patient responded on an individual level. We then provided this information to the physician as a new recommended treatment based on the patient’s response. The results were promising, with 25% of patients in the tested group showing no progression even after four years, while sadly, all patients in the control group experienced cancer progression over the course of one year.”

Despite concerns about the potential job displacement caused by AI, Professor Hopkins sees it as a “potential new industrial revolution.” Exscientia currently employs nearly 500 people, with over 350 based in the UK, and has offices and laboratories worldwide. He believes that AI creates new types of jobs and emphasizes that AI is not a general intelligence with human characteristics but rather a mathematics-based technology. It does not change what makes us human or diminish the need for empathy, compassion, and understanding in our interpersonal relationships.

Frequently Asked Questions (FAQ)

1. What is AI in drug discovery?

AI in drug discovery refers to the use of artificial intelligence technologies, such as machine learning and deep learning, to accelerate and optimize the process of discovering and creating new medications. By leveraging vast amounts of data and computational power, AI algorithms can identify patterns, predict drug efficacy, and suggest potential drug candidates.

2. How does AI revolutionize drug development?

AI revolutionizes drug development by expediting the identification of potential drug candidates, optimizing molecular design, and predicting drug efficacy. It enables researchers to conduct virtual experiments and simulations, reducing the need for costly and time-consuming laboratory experiments. This accelerates the drug development timeline and improves the success rate of clinical trials.

3. What is precision medicine?

Precision medicine is an approach to healthcare that takes into account individual variability in genes, environment, and lifestyle for each person. It involves tailoring medical treatments and interventions to the specific characteristics of each patient, leading to more targeted and effective therapies.

Sources:
Exscientia Official Website
Nature Medicine: Transforming drug discovery through AI